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A C C E P T E D M A N U S C R I P T protonated molecules for each compound by QTOFMS following atmospheric pressure chemical ionization.
The accuracy of quantification of the parent-calibrated NCD method was compared with that of the corresponding parent-calibrated QTOFMS method, as well as with a reference QTOFMS method calibrated with the authentic reference standards. The NCD method produced an equally good accuracy to the reference method for α-PVP, M3 and M5, while a higher negative bias (25%) was obtained for M1, best explainable by recovery and stability issues. The performance of the parent-calibrated QTOFMS method was inferior to the reference method with an especially high negative bias (60%) for M1. The NCD method enabled better quantitative precision than the QTOFMS methods. To evaluate the novel approach in casework, twenty postmortem urine samples previously found positive for α-PVP were analyzed by the parent calibrated NCD method and the reference QTOFMS method. The highest difference in the quantitative results between the two methods was only 33%, and the NCD method's precision as the coefficient of variation was better than 13%.
The limit of quantification for the NCD method was approximately 0.25 µg/mL in urine, which generally allowed the analysis of α-PVP and the main metabolite M1. However, the sensitivity was not sufficient for the analysis and case interpretation. Among the hundreds of NPS recognized during the ten previous years, the stimulant alpha-pyrrolidinovalerophenone (α-PVP) has turned out to be one of the more established drugs on the illicit market despite scheduling as a controlled substance in many countries. α-PVP belongs to the "second generation" cathinones that appeared on the illicit market in Europe in 2011 following the "first generation" cathinones 3,4-methylenedioxypyrovalerone (MDPV), 3,4-methylenedioxymethcathinone (methylone), and 4-methylmethcathinone (mephedrone). Current studies suggest that the potency of cathinones to reinforce responding in animal studies, and consequently increased abuse liability, is related to their capacity to inhibit dopamine uptake (Gannon 2017 ). α-PVP has more dopaminergic than serotonergic properties compared with amphetamine analogues (Liechti 2015 Qualitative screening for a broad range of NPS in biological samples is feasible by modern analytical techniques, notably taking advance of the specificity and flexibility of high-resolution mass spectrometry.
Accurate mass-based identification of NPS in data-independent acquisition mode is particularly useful since it enables immediate suspect screening, while subsequent confirmation can be accomplished once a reference standard has been obtained (Pasin 2017). However, quantification still remains a major challenge. Continuous appearance and disappearance of NPS complicates the acquisition of authentic reference standards because the standards are expensive and difficult to obtain in a sufficiently short period of time. Metabolites of NPS are
rarely commercially available, and consequently expensive custom syntheses may be required to include the most important metabolites in the analysis panel.
It is well recognized that the present-day routine analytical method, liquid chromatography electrospray triple quadrupole tandem mass spectrometry (LC-ESI-MS/MS), is at best suitable only for semi-quantitative estimation of metabolite concentrations when using the parent drug for calibration, because of the large variation in responses between the compounds (Hatsis 2017). However, there are non-MS techniques available that provide a more universal response (Magnusson 2015 , Viinamäki 2016 . Nitrogen chemiluminescence detection (NCD) shows equimolar response to nitrogen that could be exploited in universal quantification of nitrogen containing compounds (Yan 2006) . In our previous studies (Removed, Removed), we introduced a novel platform for simultaneous identification and quantification of NPS in the absence of authentic reference standards. The instrumentation consisted of gas chromatography (GC) coupled to NCD and atmospheric pressure chemical ionization quadrupole time-of-flight mass spectrometry (APCI-QTOFMS). The GC flow was divided in appropriate proportions between NCD and QTOFMS to achieve quantification and identification, respectively. We obtained promising quantitative results by analyzing blood samples that were spiked post-extraction to avoid emphasizing recovery issues (Removed). In addition, we were able to show that taking advantage of the accurate mass measurement of the protonated molecule and product ions by GC-APCI-QTOFMS, the obtained MS/MS spectra were comparable to existing soft-ionization mass spectral libraries (removed).
In the present study, our objective was to advance the concept further by developing a quantitative analysis method, based on the GC-NCD-APCI-QTOFMS platform, for α-PVP and its three metabolites in urine samples using the parent drug for calibration. Following liquid-liquid extraction, a derivatization step was introduced to avoid undesirable adsorption of polar metabolites in the GC inlet and column (Kataoka 1996 , Segura 1998 ).
Thereafter, post-mortem urine samples previously found positive for α-PVP were re-analyzed by the developed method to reveal the metabolite concentrations. Sample preparation Blank urine samples from five healthy volunteers were used for the validation experiments. The blank urines did not contain co-eluting nitrogen-containing components that would interfere with quantification at NCD. Blank urine aliquots were spiked to create external calibration curves for MS and NCD quantifications. Each reference standard was dissolved in methanol to obtain a 1 mg/mL stock solution.
Materials and methods
The stock solution was diluted to obtain a working solution containing a mixture of α-PVP and metabolites M1, M3 and M5 within a concentration range of 0.4-200 µg/mL. Blank urine (1 mL) was spiked with 25 µL of the working solution to prepare solutions ranging from 0.01 to 5 µg/mL. Twenty post-mortem urine samples from medico-legal autopsies, previously identified as positive for α-PVP, were selected for metabolite quantification. In such samples where the analytes caused a signal saturation to the mass selective detector the urine volume was adjusted to match 0.2-1 µg/mL concentration.
The pH of the urine samples was adjusted by mixing with 400 µL of 1 M Tris buffer (pH 11) and 40 µL of 1 M NaOH in a 6-mL centrifuge tube, resulting in a pH between 10 -12. The mixture was extracted with 500 µL of ethyl acetate + butyl chloride (75 + 25) in a vortex mixer for 2 min. After centrifugation, an aliquot (100 µL) of the organic phase was transferred into a conical autosampler vial. For the derivatization procedure, the organic phase was mixed with 40 µL of MSTFA + 1 % TMCS silylation reagent, incubated for 15 min at 50 ºC and mixed prior to GC injection.
Instrumentation A 7890B Series GC System equipped with a 7693 Automatic Liquid Sampler and a split/splitless injector was coupled through a two-way splitter with makeup gas (He) to an Agilent 6540 UHD Accurate-Mass QTOF mass analyser and a 255 Nitrogen Chemiluminescence Detector (all Agilent Technologies, Santa Clara, CA, USA).
Nitrogen chemiluminescence detection Pyrolysis of the analytes at NCD was carried out at 900 °C using a hydrogen flow rate of 4 mL/min and an oxygen flow rate of 9.4 mL/min. Data from NCD was collected at 50
Hz over the entire course of the analysis. OpenLab CDS Chemstation GC driver A.02.05.021 was used to control GC-NCD.
External calibration was performed after each data acquisition sequence, using the equimolar nitrogen response to α-PVP. Three calibration points (0.25, 1 and 5 µg/mL) were measured in spiked blank urine samples after extraction and derivatization.
The amount of nitrogen was calculated by multiplying the relative amount of nitrogen in the molecule by concentration, dilution factor caused by the derivatization reagent, and injection volume.
Gas chromatography
Injector liner was a Single taper Ultra Inert liner with glass wool (Agilent 5190-2293).
Analytical column was a DB-5MS (30 m × 0.25 mm id with 0.1 µm film) capillary column (Agilent Technologies). After the analytical column, the GC flow was divided between the NCD and the APCI ion source through a two-way splitter, using 0.55 m x 0.18 mm and 2 m x 0.18 mm uncoated deactivated fusedsilica post-columns to obtain a 10:1 flow ratio, respectively. The splitter pressure was 15.8 psi and the flow ratio was calculated using the Effluent Splitter Calculator (with Makeup) (Agilent Technologies). In this concurrent detection, the NCD signal is detected 0.02 minutes earlier than QTOFMS.
GC was operated in the pulsed splitless injection mode with an equilibration time of 0.75 min and 50 mL/min purge flow to split vent at 0.75 min. A pulse pressure of 50 psi for 0.75 min was applied prior to using initial head pressure of 24.9 psi. The injector port temperature was 250°C and the transfer line temperature 320°C.
The injection volume was 1.0 µL. The oven temperature was initially held at 100°C for 0.75 min and then increased by 30°C per min to 320°C, which was held for 6 min. Helium was used as carrier gas at 1 mL/min in the constant flow mode.
Mass Spectrometry QTOFMS was operated in APCI positive ionization mode, drying gas (nitrogen) flow at 5.0 L/min and gas temperature at 365°C. Corona discharge needle current was 1000 nA and capillary voltage 1000 V. Fragmentor voltage was 140 V and skimmer voltage 65 V.
Mass acquisition was performed in All-ions mode, and data were recorded over the m/z range of 50-400 with an acquisition rate of 5 spectra/s. Collision energy in the low energy function was 0 eV, whereas in the high energy function 10 and 20 eV were used. External mass calibration was carried out using the APCI tuning mix (Agilent Technologies). Ion m/z 257.2475 was used for internal calibration throughout the chromatographic separation. QTOFMS was operated in 2 GHz, Extended Dynamic Range mode.
All data were collected with MassHunter Data Acquisition B.04.00 software (Agilent Technologies).
MassHunter Profinder B.06.00 software (Agilent Technologies) was used for initial data processing and compound identification. for Forensic Toxicology SWGTOX, 2013), where appropriate. Limit of detection (LOD) was determined using the following criteria for tentative identification: peak area of >1000, retention time tolerance of 0.1 min, and mass tolerance of 1 mDa. All the quantitative data, including the limit of quantification (LOQ), bias, and precision, were gathered from parallel measurements of five calibration points ranging from 0.01 to 1 µg/mL in spiked control urine samples (Tables 1 and 2 ). Processed sample stability at room temperature at concentrations of 0.01 and 1.0 µg/mL was tested by measuring the difference from the averaged time zero (to) response within a 10 h interval. Selectivity was measured from actual post-mortem samples. An experimental setting was designed that simulated a quantitative analysis having no authentic reference standards for the metabolites and using the parent drug instead for quantitative calibration, assuming that the extraction recovery of the parent drug equals that of the metabolites. Table 1 shows the accuracy of quantification of the parent-calibrated NCD method, compared with that of the corresponding parent-calibrated QTOFMS method and a reference QTOFMS method calibrated with the authentic reference standards. The NCD method produced generally a better quantitative precision than the QTOFMS methods. The NCD method showed an equally good accuracy to the reference method for α-PVP, M3 and M5, but a higher negative bias (24 -25%) was obtained for M1. The bias was due to a combined effect of lower extraction recovery and relative instability of the TMS derivative of M1. Cleavage of the TMS derivative was verified as an increase of free M1 with time, and consequently it is recommended to minimize the storage time of the prepared samples prior to analysis. The parent-calibrated QTOFMS method performed worse than the reference method with an especially high negative bias (58 -60%) for M1. This result is obviously due to the differences in the ionization efficiency in the APCI source, in addition to the lower extraction recovery and instability issues.
Results & Discussion

Method validation with spiked urine samples
Table 1.
Accuracy of quantification of parent drug -calibrated NCD method, parent drug -calibrated QTOFMS method and reference QTOFMS method calibrated with authentic reference standards. a Acceptance criteria for all method validation parameters determined are summarized in Table 2 . Table 2 .
GC-NCD calibrated with α-PVP
GC-NCD-APCI-QTOFMS method validation results for α-PVP, M1, M3 and M5. At NCD all compounds are pyrolyzed prior to the chemiluminescent detection. This ensures that the response of most nitrogen-containing compounds is equimolar regardless of the molecular structure or condition, with a notable exception of adjacent nitrogen atoms as pointed out by Yan (2006) . The fact that neither of the parentcalibrated methods was capable of fully compensating the extraction recovery of M1 emphasizes the importance of developing a sample preparation method as generic as possible. However, acceptable levels of accuracy were reached using the parent-calibrated NCD method contrary to the parent-calibrated QTOFMS method. Indeed, quantification of metabolites by MS in the absence of authentic reference standards is at best only semi-quantitative. A study by Hatsis et al. (2017) found up to a 70-fold difference in ion response factor between metabolite and parent drug by ESI-LC-MS/MS.
Parameter
Investigation of post-mortem urine samples
To evaluate the novel GC-NCD-APCI-QTOFMS platform in casework, twenty post-mortem urine samples previously found positive for α-PVP were analyzed by the parent-calibrated NCD method and the reference QTOFMS method. Table 3 shows that by using the parent-calibrated NCD method a quantitative result was obtained in 12 out of 20, 11/20, 2/20 and 0/20 cases for α-PVP, M1, M3 and M5, respectively. The highest difference in the quantitative results between the two methods was only 33%, and the NCD method's precision expressed as the coefficient of variation was better than 13%. The accuracy and precision of quantification for post-mortem samples was similar to that for the spiked urine samples by the parent-calibrated NCD method (Table 3) . Table 3 .
Comparison of measured drug concentrations in twenty post-mortem urine samples between GC-APCI-
QTOFMS calibrated with authentic reference standards and GC-NCD calibrated with α-PVP. Moreover, interference caused by co-eluting nitrogen compounds prevented reliable determination in some cases with lower metabolite concentrations (Fig 4) . (m/z 250.1622) contributes only minimally to total NCD peak area.
According to the manufacturer, the NCD detector can detect nitrogen over the carbon background signal in the mass ratio of 10 7 to one. However, co-eluting nitrogen-containing compounds can cause overestimation in NCD quantification. Such compounds can be due to a multidrug intake or they can be common endogenous urine compounds which are prevalent at low concentrations. In Table 2 we have set criteria for assessing the quality of the quantitative data. For high-sensitivity NCD analysis, common matrix background peaks should be subtracted using a blank urine. A viable strategy to enhance chromatographic selectivity would be using two-dimensional GC (Mommers, 2016) .
Conclusions
This study demonstrated that the current GC-NCD-APCI-QTOFMS instrument platform has potential in the rapid quantitative bioanalysis of the main α-PVP metabolites together with the parent drug in cases where authentic reference standards are not immediately available. As conventional validated analysis necessitates information on retention time, compound specific spectral fragmentation and quantitative response obtained with an authentic reference standard, these conditions cannot be realized in case of infrequently encountered NPS metabolites. However, identifying NPS metabolites would facilitate the confirmation of the parent drugs, and metabolite quantification can aid forensic interpretation, in particular when investigating the time of drug intake utilizing metabolite to parent drug ratios. In future studies we will seek to improve the NCD method's LOQ using the large volume injection and widen the scope of substances included in the NPS screening. 
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